SecBot SecBot

Prescription Information Modernization Act of 2025

H.R. 4132 Rep. Diana Harshbarger (R-TN-1) In committee
Bill text PDF
  1. Introduced Jun 25
  2. Committee Jun 25
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Jun 25, 2025Next: House vote
490d ago Jun 25, 2025: Referred to the House Committee on Energy and Commerce.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
3companies, 15 filings
Subscribe to see spend
Member trades
1trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

3 companies
Companies by sector
Biotech & Pharma 2Medical Devices & Healthcare 1
Search all 3 companies, their asks and price moves Subscribe

Summary

This bill allows manufacturers of prescription drugs and biological products to provide FDA-approved prescribing information solely in digital form, while ensuring that prescribers and dispensers can still receive paper copies if they choose. It requires the Secretary of Health and Human Services to issue regulations within one year to implement this change and provide instructions for health care professionals to request paper copies, with the goal of minimizing economic impacts on them. Within two years, the Secretary must hold a public workshop to discuss improving the format and usability of prescribing information. The digital-only option applies to drugs introduced into interstate commerce two years after enactment or when final regulations take effect, whichever is sooner.

Summary of the bill text as introduced in House (Jun 25, 2025), generated by SecBot from the official bill text; the Library of Congress summary is not yet published.

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.